Patent Yard Sign in
Canadian application, no grantCanada

Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound

CA 2333320 A1 · Owner: Hegele-Hartung, Christa · Inventors: Hegele-Hartung, Christa; Cam, Quoc-Lam

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to a pharmaceutical composition comprising c-AMPincreasing compounds in low dose and at least one meiosis-stimulating compound for the treatment of infertility and to the use of low dose c-AMP-increasing compounds alone or in combination with at least one meiosis-stimulating compound to increase the rate of fertilization in a mammal and for the preparation of medicaments. The preferred c-AMP-increasing compound is Hypoxanthine. The meiosis-stimulating compound is FF-MAS (4,4-dimethyl-5alphacholest-8,14,24-trien-3beta-ol).

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 7, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 7, 2019.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 7, 2021.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 7, 1999
GrantedNo grant recorded
Term endedMay 7, 2019
Patent numberCA 2333320 A1
Classification (IPC)A61K31/52 +2 more

Timeline

Timeline From CIPO dates

2000200220042006200820102012201420162018Application filedMay 7, 1999Term endedMay 7, 2019

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.